Celldex TherapeuticsCLDX
13F holders, Q2 2026 (June 30)253holders +25
44new positions
21sold out
5famous investors
$37.21avg. 13F price*
At the end of Q2 2026, 253 institutions reported holding Celldex Therapeutics Inc. (CLDX) in their 13F filings, up 25 from Q1 2026. 44 opened new positions and 21 sold out. The largest holders were Wellington Management Group LLP ($355.1M), BlackRock, Inc. ($260.6M) and Kynam Capital Management, LP ($198.1M). 5 famous investors held it, including Israel Englander (0.0% of Millennium Management's portfolio), Ken Fisher (0.0% of Fisher Asset Management's portfolio) and Steve Cohen (0.0% of Point72 Asset Management's portfolio).
- Company
- Celldex Therapeutics Inc.
- CUSIP
- 15117B202
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2026 → Q2 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 44 | $104.5M |
| Exits | 21 | $58.5M |
All 13F filers, Q1 2026 → Q2 2026: 21,359,984 shares bought and 8,933,202 shares sold, net +12,426,782 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 253 holders
| Wellington Management Group LLP | 0.06% | Add +11.5% | 9,543,671 | $355.1M |
| BlackRock, Inc. | 0.00% | Add +30.4% | 7,002,530 | $260.6M |
| Kynam Capital Management, LP | 10.95% | Reduce -8.9% | 5,322,908 | $198.1M |
| T. Rowe Price Associates Inc. | 0.02% | Add +124.6% | 4,685,223 | $174.3M |
| State Street Corp. | 0.00% | Add +39.1% | 3,900,427 | $145.1M |
| FMR LLC | 0.01% | Reduce -0.7% | 3,722,888 | $138.5M |
| Vanguard Capital Management LLC | 0.00% | Add +17.0% | 3,464,831 | $128.9M |
| Deep Track Capital, LP | 1.61% | Add +128.9% | 2,939,151 | $109.4M |
| Logos Global Management LP | 3.36% | Add +366.7% | 2,100,000 | $78.1M |
| Geode Capital Management, LLC | 0.00% | Add +19.8% | 2,022,226 | $75.3M |
| Eversept Partners, LP | 3.62% | Reduce -0.1% | 1,785,941 | $66.5M |
| Goldman Sachs Group Inc. | 0.01% | Add +63.4% | 1,615,343 | $60.1M |
| Commodore Capital LP | 2.99% | Reduce -49.9% | 1,350,000 | $50.2M |
| Bellevue Group AG | 0.94% | No change | 1,200,000 | $44.7M |
| Baker Bros. Advisors LP | 0.22% | Add +77.7% | 1,182,611 | $44.0M |
| Millennium Management | 0.03% | Reduce -6.6% | 1,170,787 | $43.6M |
| Dimensional Fund Advisors LP | 0.01% | Add +1.4% | 1,073,985 | $40.0M |
| American Century Companies Inc. | 0.02% | Add +21.7% | 1,042,395 | $38.8M |
| Eventide Asset Management, LLC | 0.52% | No change | 1,037,000 | $38.6M |
| Novo Holdings A/S | 2.21% | Reduce -14.6% | 1,025,000 | $38.1M |
| Elmind Capital, LP | 9.25% | Add +14.4% | 990,000 | $36.8M |
| Driehaus Capital Management LLC | 0.21% | New | 989,442 | $36.8M |
| Fisher Asset Management | 0.01% | Reduce -2.8% | 985,677 | $36.7M |
| Pictet Asset Management Holding SA | 0.03% | Reduce -0.7% | 917,408 | $34.1M |
| Foresite Capital Management VI LLC | 5.09% | Add +178.5% | 879,713 | $32.7M |
| Vanguard Portfolio Management LLC | 0.00% | Add +37.2% | 863,536 | $32.1M |
| Assenagon Asset Management S.A. | 0.04% | Add +438.3% | 788,696 | $29.3M |
| Northern Trust Corp. | 0.00% | Add +24.7% | 719,647 | $26.8M |
| Woodline Partners LP | 0.08% | Add +40.1% | 700,830 | $26.1M |
| Affinity Asset Advisors, LLC | 1.29% | Add +40.0% | 700,000 | $26.0M |
| Rock Springs Capital Management LP | 1.27% | Add +7.5% | 699,146 | $26.0M |
| Two Sigma Investments, LP | 0.02% | Add +382.6% | 661,235 | $24.6M |
| Charles Schwab Investment Management Inc. | 0.00% | Add +20.3% | 655,954 | $24.4M |
| Algert Global LLC | 0.29% | Add +201.1% | 647,836 | $24.1M |
| ADAR1 Capital Management, LLC | 1.09% | Add +44.8% | 619,542 | $23.1M |
| Bank of America Corp. | 0.00% | Reduce -14.3% | 607,195 | $22.6M |
| Panagora Asset Management Inc. | 0.07% | Add +302.3% | 572,538 | $21.3M |
| Nuveen, LLC | 0.01% | Add +181.5% | 568,460 | $21.2M |
| Vanguard Fiduciary Trust Co. | 0.00% | Add +28.7% | 552,973 | $20.6M |
| 5AM Venture Management, LLC | 6.43% | No change | 497,270 | $18.5M |
| Federated Hermes, Inc. | 0.03% | New | 492,893 | $18.3M |
| UBS Group AG | 0.00% | Add +62.3% | 481,997 | $17.9M |
| Candriam S.C.A. | 0.08% | Add +72.5% | 481,125 | $17.9M |
| Ikarian Capital, LLC | 2.91% | Add +3.7% | 478,500 | $17.8M |
| Braidwell LP | 0.62% | Reduce -67.8% | 436,646 | $16.2M |
| Redmile Group, LLC | 1.08% | Add +65.9% | 433,921 | $16.1M |
| Citigroup Inc. | 0.01% | Add +86.2% | 404,703 | $15.1M |
| Palo Alto Investors LP | 2.06% | Add +34.9% | 399,856 | $14.9M |
| TSP Capital Management Group, LLC | 3.30% | New | 371,127 | $13.8M |
| PFM Health Sciences, LP | 1.11% | Add +5.5% | 342,751 | $12.8M |
| Kennedy Capital Management LLC | 0.23% | Reduce -2.8% | 342,328 | $12.7M |
| Segall Bryant & Hamill, LLC | 0.15% | Reduce -3.1% | 336,291 | $12.5M |
| Tetragon Partners GP Ltd | 1.76% | Reduce -7.0% | 290,441 | $10.8M |
| Superstring Capital Management LP | 6.76% | Add +59.7% | 287,583 | $10.7M |
| GordonMD Global Investments LP | 5.04% | Add +64.2% | 279,720 | $10.4M |
| SummitTX Capital, L.P. | 0.25% | Add +7.7% | 254,959 | $9.5M |
| Sphera Funds Management LTD. | 1.28% | Reduce -1.1% | 240,868 | $9.0M |
| Bank of New York Mellon Corp | 0.00% | Add +17.7% | 224,176 | $8.3M |
| Rosalind Advisors, Inc. | 2.80% | Reduce -39.4% | 200,000 | $7.4M |
| Morgan Stanley | 0.00% | Reduce -9.5% | 196,974 | $7.3M |
| Universal- Beteiligungs- und Servicegesellschaft mbH | 0.01% | Add +179.5% | 195,788 | $7.3M |
| Trexquant Investment LP | 0.04% | New | 184,524 | $6.9M |
| Mirador Capital Partners LP | 0.83% | Add +1.7% | 181,054 | $6.7M |
| Stempoint Capital LP | 1.15% | Reduce -29.8% | 178,412 | $6.6M |
| Corient Private Wealth LP | 0.01% | Add +1109.0% | 176,956 | $6.6M |
| Deutsche Bank AG | 0.00% | Add +23.5% | 176,592 | $6.6M |
| JPMorgan Chase & Co. | 0.00% | Reduce -4.6% | 157,241 | $6.0M |
| Cinctive Capital Management LP | 0.22% | Add +253.2% | 145,637 | $5.4M |
| Boothbay Fund Management, LLC | 0.10% | Add +3.8% | 140,064 | $5.2M |
| First Trust Advisors LP | 0.00% | Add +102.5% | 138,682 | $5.2M |
| Swiss National Bank | 0.00% | Add +14.5% | 135,000 | $5.0M |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 0.00% | Add +11.7% | 134,958 | $5.0M |
| Montanova Capital, LLC | 0.09% | New | 121,297 | $4.5M |
| Connor, Clark & Lunn Investment Management Ltd. | 0.01% | Reduce -34.6% | 120,428 | $4.5M |
| Point72 Asset Management | 0.01% | Reduce -96.4% | 117,217 | $4.4M |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | 0.00% | Reduce -4.4% | 117,045 | $4.4M |
| Jump Financial, LLC | 0.04% | Add +1218.5% | 116,293 | $4.3M |
| Rhumbline Advisers | 0.00% | Add +22.1% | 104,963 | $3.9M |
| Propel Bio Management, LLC | 2.02% | Reduce -21.1% | 103,695 | $3.9M |
| Invesco Ltd. | 0.00% | Add +10.1% | 103,131 | $3.8M |
| Russell Investments Group, Ltd. | 0.00% | Add +1083.0% | 100,452 | $3.7M |
| Integral Health Asset Management, LLC | 0.15% | New | 100,000 | $3.7M |
| Odyssean, LLC | 0.58% | New | 95,069 | $3.5M |
| Manufacturers Life Insurance Company, The | 0.00% | Add +14.9% | 89,338 | $3.3M |
| HighVista Strategies LLC | 0.74% | Reduce -2.7% | 86,964 | $3.2M |
| AQR Capital Management | 0.00% | Add +1017.3% | 86,893 | $3.2M |
| Seven Fleet Capital Management LP | 0.53% | Add +195.8% | 86,664 | $3.2M |
| PDT Partners, LLC | 0.16% | Reduce -17.3% | 80,899 | $3.0M |
| TD Asset Management Inc | 0.00% | Add +12.8% | 79,326 | $3.0M |
| Alps Advisors Inc. | 0.01% | Add +46.1% | 79,165 | $2.9M |
| Wells Fargo & Company | 0.00% | Add +122.4% | 78,176 | $2.9M |
| California State Teachers Retirement System | 0.00% | Reduce -2.4% | 77,723 | $2.9M |
| Alliancebernstein L.P. | 0.00% | Add +35.3% | 88,640 | $2.8M |
| XTX Topco Ltd | 0.04% | Add +522.3% | 75,135 | $2.8M |
| Birchview Capital, LP | 1.22% | Reduce -0.3% | 69,900 | $2.6M |
| Quantinno Capital Management LP | 0.00% | Add +5.0% | 69,048 | $2.6M |
| DAFNA Capital Management LLC | 0.49% | No change | 68,518 | $2.5M |
| Man Group plc | 0.00% | New | 63,504 | $2.4M |
| Teachers Retirement System of the State of Kentucky | 0.02% | Add +80.5% | 59,732 | $2.2M |
| Legal & General Group Plc | 0.00% | Add +8.1% | 59,551 | $2.2M |
"% of holder's portfolio" is CLDX's weight in each manager's 13F, not the share of Celldex Therapeutics Inc. the manager owns.